Guardian Science Weekly

Why does Elon Musk want to buy Twitter?

Loading player...
Back in April this year, Tesla chief executive Elon Musk signed a $44bn (£40bn) takeover agreement for Twitter. But, in July, the world’s richest man said he was walking away from the controversial deal, arguing Twitter has more spam accounts than it claims. Then, last week, Musk offered to complete the acquisition in a dramatic U-turn. So what might happen next? Ian Sample talks to the Guardian’s global technology editor, Dan Milmo, about why Musk wants to own the social media platform, hears about the twists and turns of the saga so far, and finds out if the takeover is ever likely to happen. Help support our independent journalism at theguardian.com/sciencepod
11 Oct 2022 English United Kingdom Science · Nature

Other recent episodes

Can a name change transform PCOS outcomes for women?

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand…
21 May 16 min

Ebola outbreak: what do we know and can it be contained?

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, which has led to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular…
18 May 13 min

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link…
14 May 21 min

Trump is backing psychedelic research: here’s why

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise…
12 May 17 min
All episodes